Impacts of Congressional Actions on Federal Contract Spending

whitePaper | November 9, 2019

The underlying driver of the ongoing US–China trade war is a race for global technological dominance. President Trump has raised a number of issues regarding trade with China – including the US’s trade deficit with China and the naming of China as a currency manipulator. But at the heart of the ongoing tariff escalation are China’s policies and practices regarding forced technology transfer, intellectual property theft and non-market distortions.

whitePaper | December 12, 2019

Artificial intelligence (AI) is everywhere — or so it seems. From navigation apps that automatically reroute us when our usual highway is clogged with traffic to banking websites that pre-approve mortgages seconds after we submit a short application, AI is expanding into our personal and professional lives more every day. Eyeing this trend, state CIOs understand AI is also likely to play an important role in modernizing the delivery of citizen services and furthering government modernization efforts. The question is, how do they separate the potential from the hype for one of today’s hottest technologies?

whitePaper | November 5, 2019

This final report of the Taskforce on Transforming the Economic Dimension of U.S. China Strategy outlines a four-part strategy for an effective U.S. response to the economic challenges presented by China.

whitePaper | March 25, 2020

The National Science and Technology Council (NSTC) is the principal means by which the Executive Branch coordinates science and technology policy across the diverse entities that make up the Federal research and development enterprise. A primary objective of the NSTC is to ensure that science and technology policy decisions and programs are consistent with the President’s stated goals. The NSTC prepares research and development strategies that are coordinated across Federal agencies aimed at accomplishing multiple national goals.

whitePaper | December 19, 2019

The U.S. labor market is the strongest it has been in the last half century, as shown by economic data across various metrics. This is partly attributable to President Trump’s progrowth economic policies, the results of which are disproportionately benefiting Americans who were previously left behind. The Administration’s policies are boosting labor demand and lowering structural barriers to entering the labor market. This report provides evidence that this labor market has contributed to reduced inequality through an economic boom that is greatly benefiting historically disadvantaged groups. These groups are becoming more and more self-reliant through their economic activity, rather than remaining inactive in the labor market to qualify for means-tested government programs.

whitePaper | December 10, 2019

The Trump administration, members of Congress from both parties, and many states have introduced proposals to combat high drug prices. Too often missing from these reform efforts, however, is a clear understanding of a root cause of the crisis: the suppression of fair market competition through various forms of monopoly. This white paper examines and proposes solutions for the two main ways that monopoly drives up the costs and lowers the quality of prescription drugs: increasing corporate concentration in the pharmaceutical industry, and the monopoly markets for individual drugs created by a deeply flawed and increasingly abused patent and regulatory system.